FY2018 EPS Estimates for Humana Inc Boosted by Oppenheimer (HUM)

Humana Inc (NYSE:HUM) – Stock analysts at Oppenheimer raised their FY2018 EPS estimates for Humana in a research note issued on Wednesday, November 7th. Oppenheimer analyst M. Wiederhorn now forecasts that the insurance provider will earn $14.40 per share for the year, up from their prior forecast of $14.15. Oppenheimer also issued estimates for Humana’s Q3 2019 earnings at $5.09 EPS and FY2019 earnings at $17.23 EPS.

Several other brokerages have also recently weighed in on HUM. Credit Suisse Group raised their price target on shares of Humana from $370.00 to $390.00 and gave the company an “outperform” rating in a research report on Thursday. MED raised their price target on shares of Humana from $350.00 to $373.00 and gave the company an “outperform” rating in a research report on Thursday. SunTrust Banks reaffirmed a “hold” rating and issued a $350.00 price target on shares of Humana in a research report on Thursday, August 2nd. Cowen began coverage on shares of Humana in a research report on Monday, September 17th. They issued a “market perform” rating and a $372.00 price target on the stock. Finally, Royal Bank of Canada reaffirmed a “hold” rating and issued a $318.00 price target on shares of Humana in a research report on Thursday, August 2nd. Seven investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Humana has an average rating of “Buy” and an average price target of $352.30.

Shares of HUM opened at $338.95 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.43 and a quick ratio of 1.43. The stock has a market capitalization of $45.71 billion, a PE ratio of 28.95, a PEG ratio of 1.65 and a beta of 1.03. Humana has a one year low of $231.90 and a one year high of $355.88.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, November 7th. The insurance provider reported $4.58 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $4.29 by $0.29. The company had revenue of $14.21 billion during the quarter, compared to the consensus estimate of $13.97 billion. Humana had a return on equity of 17.43% and a net margin of 2.48%. During the same period last year, the business posted $3.39 EPS.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 25th. Shareholders of record on Monday, December 31st will be given a dividend of $0.50 per share. The ex-dividend date is Friday, December 28th. This represents a $2.00 annualized dividend and a dividend yield of 0.59%. Humana’s dividend payout ratio is currently 17.08%.

In other Humana news, insider Elizabeth D. Bierbower sold 3,092 shares of Humana stock in a transaction that occurred on Thursday, August 16th. The shares were sold at an average price of $330.00, for a total transaction of $1,020,360.00. Following the transaction, the insider now owns 14,289 shares of the company’s stock, valued at approximately $4,715,370. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Bruce D. Broussard sold 18,000 shares of Humana stock in a transaction that occurred on Monday, September 10th. The stock was sold at an average price of $328.66, for a total transaction of $5,915,880.00. Following the transaction, the chief executive officer now directly owns 71,085 shares in the company, valued at approximately $23,362,796.10. The disclosure for this sale can be found here. 0.60% of the stock is owned by company insiders.

Several institutional investors have recently bought and sold shares of the business. Raymond James Trust N.A. lifted its position in shares of Humana by 19.8% during the 2nd quarter. Raymond James Trust N.A. now owns 956 shares of the insurance provider’s stock worth $284,000 after buying an additional 158 shares in the last quarter. Financial Gravity Wealth Inc. lifted its position in shares of Humana by 41.9% during the 3rd quarter. Financial Gravity Wealth Inc. now owns 562 shares of the insurance provider’s stock worth $179,000 after buying an additional 166 shares in the last quarter. Daiwa SB Investments Ltd. lifted its position in shares of Humana by 27.9% during the 2nd quarter. Daiwa SB Investments Ltd. now owns 780 shares of the insurance provider’s stock worth $232,000 after buying an additional 170 shares in the last quarter. Advisor Partners LLC lifted its position in shares of Humana by 5.3% during the 2nd quarter. Advisor Partners LLC now owns 3,604 shares of the insurance provider’s stock worth $1,073,000 after buying an additional 180 shares in the last quarter. Finally, San Francisco Sentry Investment Group CA lifted its position in shares of Humana by 46.9% during the 3rd quarter. San Francisco Sentry Investment Group CA now owns 598 shares of the insurance provider’s stock worth $203,000 after buying an additional 191 shares in the last quarter. 92.62% of the stock is currently owned by hedge funds and other institutional investors.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Featured Article: Stock Symbol

Earnings History and Estimates for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply